ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,342
Diagnostic referrals
1,012
Outstanding pathways
298

Screening pathway

  1. Screening5,342Encounters
  2. Positive finding1,866Documented findings
  3. Referral1,012Diagnostic referrals
  4. Follow-up1,269Diagnostic visits
  5. Outcome714Resolved pathways

Stage totals use different units. Pending pathways: 298. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2027-05-11, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R
  12. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  13. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4768 · Expanded synthetic participant 4768Site E — Resource-Constrained Navigation Programme
EXP-4769 · Expanded synthetic participant 4769Site D — Community Engagement Programme
EXP-4770 · Expanded synthetic participant 4770Site A — Urban Referral Hub
EXP-4771 · Expanded synthetic participant 4771Site A — Urban Referral Hub
EXP-4772 · Expanded synthetic participant 4772Site C — Rural Outreach Programme
EXP-4773 · Expanded synthetic participant 4773Site C — Rural Outreach Programme
EXP-4775 · Expanded synthetic participant 4775Site A — Urban Referral Hub
EXP-4777 · Expanded synthetic participant 4777Site A — Urban Referral Hub
EXP-4778 · Expanded synthetic participant 4778Site C — Rural Outreach Programme
EXP-4779 · Expanded synthetic participant 4779Site D — Community Engagement Programme
EXP-4780 · Expanded synthetic participant 4780Site B — Peri-Urban Access Programme
EXP-4781 · Expanded synthetic participant 4781Site C — Rural Outreach Programme
EXP-4785 · Expanded synthetic participant 4785Site A — Urban Referral Hub
EXP-4786 · Expanded synthetic participant 4786Site C — Rural Outreach Programme
EXP-4789 · Expanded synthetic participant 4789Site D — Community Engagement Programme
EXP-4790 · Expanded synthetic participant 4790Site C — Rural Outreach Programme
EXP-4791 · Expanded synthetic participant 4791Site A — Urban Referral Hub
EXP-4792 · Expanded synthetic participant 4792Site B — Peri-Urban Access Programme
EXP-4793 · Expanded synthetic participant 4793Site D — Community Engagement Programme
EXP-4794 · Expanded synthetic participant 4794Site E — Resource-Constrained Navigation Programme
EXP-4795 · Expanded synthetic participant 4795Site E — Resource-Constrained Navigation Programme
EXP-4796 · Expanded synthetic participant 4796Site B — Peri-Urban Access Programme
EXP-4797 · Expanded synthetic participant 4797Site A — Urban Referral Hub
EXP-4799 · Expanded synthetic participant 4799Site D — Community Engagement Programme
EXP-4801 · Expanded synthetic participant 4801Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1963
HPV DNA
2655
Cytology
724

Navigation activity

Barrier documented
922
Contact attempt
1480
Navigation intervention
414
Diagnostic booking
1282
Diagnostic visit
1269

Documented barriers

Contact difficulty
295
Transport difficulty
305
Appointment coordination
322

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.